Search Results Search Sort by RelevanceMost Recent Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518. Medicine and Society Aug 2022 How Biased and Carceral Responses to Persons With Mental Illness in Acute Medical Care Settings Constitute Iatrogenic Harms Carmen Black, MD and Amanda Calhoun, MD, MPH Neglected examples of iatrogenic harm involve persons with severe mental illness who seek inpatient care. AMA J Ethics. 2022;24(8):E781-787. doi: 10.1001/amajethics.2022.781. Original Research Jun 2022 لماذا نحتاج إلى رقابة أكثر صرامة على البحوث التي تشمل الأشخاصالمتأثرين بالصراع Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS AMA J Ethics. 2022;E518-529. doi: 10.1001/amajethics.2022.518. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Case and Commentary Aug 2023 Should Organizational Investment in Robotic Surgical Technology Ever Influence Surgeons’ Decisions About Surgical Approach to Patients’ Surgical Care? Ryan D. Rosen, DO and David A. Edelman, MD, MSHPEd Costs partly determine organizational robotics, but questions remain about whether and to what extent they should influence care decisions. AMA J Ethics. 2023;25(8):E575-582. doi: 10.1001/amajethics.2023.575.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518.
Medicine and Society Aug 2022 How Biased and Carceral Responses to Persons With Mental Illness in Acute Medical Care Settings Constitute Iatrogenic Harms Carmen Black, MD and Amanda Calhoun, MD, MPH Neglected examples of iatrogenic harm involve persons with severe mental illness who seek inpatient care. AMA J Ethics. 2022;24(8):E781-787. doi: 10.1001/amajethics.2022.781.
Original Research Jun 2022 لماذا نحتاج إلى رقابة أكثر صرامة على البحوث التي تشمل الأشخاصالمتأثرين بالصراع Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS AMA J Ethics. 2022;E518-529. doi: 10.1001/amajethics.2022.518.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Case and Commentary Aug 2023 Should Organizational Investment in Robotic Surgical Technology Ever Influence Surgeons’ Decisions About Surgical Approach to Patients’ Surgical Care? Ryan D. Rosen, DO and David A. Edelman, MD, MSHPEd Costs partly determine organizational robotics, but questions remain about whether and to what extent they should influence care decisions. AMA J Ethics. 2023;25(8):E575-582. doi: 10.1001/amajethics.2023.575.